申请人:E. R. Squibb & Sons, Inc.
公开号:US04337201A1
公开(公告)日:1982-06-29
Esters of phosphinylalkanoyl prolines and phosphinylalkanoyl substituted prolines are inhibitors of angiotensin converting enzyme and are useful in the treatment of hypertension.
磷酰基丙氨酰脯氨酸酯和磷酰基丙氨酰取代脯氨酸酯是抑制血管紧张素转化酶的抑制剂,并且在治疗高血压方面具有用处。